Cancers in people with HIV: who gets them, and which ones?
Circumcision reduces HIV incidence in Ugandan men and herpes prevalence in South Africans
Superinfection: second HIV infections happen as often as first ones
Novel integrase inhibitor dolutegravir still potent at 96 weeks
Controversy regarding strategic treatment interruptions in young children who start ART during infancy
Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study
When does viral load testing add value in sub-Saharan Africa?
PEPFAR funding linked to lower death rate from all causes in Africa
Tenofovir rectal microbicide safe; may have direct effect on tissues as well as virus
